{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:46:38Z","timestamp":1793731598201,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["RS-2023-00272216"],"award-info":[{"award-number":["RS-2023-00272216"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Microbiology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.vetmic.2024.110151","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T22:42:15Z","timestamp":1718145735000},"page":"110151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparative immunogenic and immunoprotective activities of PCV2d Cap and Rep antigens delivered by an efficient eukaryotic expression system engineered into a Salmonella vaccine vector"],"prefix":"10.1016","volume":"295","author":[{"given":"Khristine Kaith S.","family":"Lloren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandran","family":"Sivasankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetmic.2024.110151_bib1","article-title":"Salmonella-Delivered COBRA-HA1 Antigen Derived from H1N1 Hemagglutinin Sequences Elicits Broad-Spectrum Protection Against Influenza A Subtypes","author":"Aganja","year":"2023","journal-title":"Engineering"},{"key":"10.1016\/j.vetmic.2024.110151_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.1300","article-title":"Protective immunity against porcine circovirus 2 in mice induced by a gene-based combination vaccination","volume":"11","author":"Aravindaram","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.vetmic.2024.110151_bib3","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1014975108","article-title":"Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice","volume":"108","author":"Bai","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vetmic.2024.110151_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2011.09.041","article-title":"Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2)","author":"Beach","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vetmic.2024.110151_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9020097","article-title":"An update on self-amplifying mRNA vaccine development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vetmic.2024.110151_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S0264-410X(03)00503-6","article-title":"Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins","volume":"21","author":"Blanchard","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2024.110151_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.vetmic.2024.110151_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2012.06.031","article-title":"Commercial porcine circovirus type 2 vaccines: Efficacy and clinical application","author":"Chae","year":"2012","journal-title":"Vet. J."},{"key":"10.1016\/j.vetmic.2024.110151_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2007.07.009","article-title":"Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments","volume":"45","author":"Fan","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.vetmic.2024.110151_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.78.12.6297-6303.2004","article-title":"A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) Cloned into the Genomic Backbone of the Nonpathogenic PCV1 Induces Protective Immunity against PCV2 Infection in Pigs","volume":"78","author":"Fenaux","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.vetmic.2024.110151_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2010.05.013","article-title":"Porcine circovirus type 2 (PCV2) Cap and Rep proteins are involved in the development of cell-mediated immunity upon PCV2 infection","volume":"137","author":"Fort","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetmic.2024.110151_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2012.09.001","article-title":"Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine","volume":"150","author":"Fort","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetmic.2024.110151_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.04.028","article-title":"One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model","volume":"27","author":"Fort","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2024.110151_bib14","doi-asserted-by":"crossref","DOI":"10.1006\/meth.2001.1261","article-title":"An overview of real-time quantitative PCR: applications to quantify cytokine gene expression","volume":"25","author":"Giulietti","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.vetmic.2024.110151_bib15","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-animal-031716-032328","article-title":"Veterinary replicon vaccines","author":"Hikke","year":"2017","journal-title":"Annu Rev. Anim. Biosci."},{"key":"10.1016\/j.vetmic.2024.110151_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2010.09.001","article-title":"Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector","volume":"28","author":"Huang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2024.110151_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/j.1462-5822.2004.00451.x","article-title":"Salmonella-induced macrophage death: multiple mechanisms, different outcomes","author":"Hueffer","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vetmic.2024.110151_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2021.07.007","article-title":"Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection","volume":"36","author":"Jawalagatti","year":"2022","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.vetmic.2024.110151_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/v9050099","article-title":"Porcine circovirus type 2 (PCV2) vaccines in the context of current molecular epidemiology","author":"Karuppannan","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vetmic.2024.110151_bib20","doi-asserted-by":"crossref","DOI":"10.1354\/vp.38-1-74","article-title":"Viral replication and lesions in BALB\/c mice experimentally inoculated with porcine circovirus isolated from a pig with postweaning multisystemic wasting disease","volume":"38","author":"Kiupel","year":"2001","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetmic.2024.110151_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-015-0157-4","article-title":"PCV2 vaccination induces IFN-\u03b3\/TNF-\u03b1 co-producing T cells with a potential role in protection","volume":"46","author":"Koinig","year":"2015","journal-title":"Vet. Res"},{"key":"10.1016\/j.vetmic.2024.110151_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1217554109","article-title":"Turning self-destructing Salmonella into a universal DNA vaccine delivery platform","volume":"109","author":"Kong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vetmic.2024.110151_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/1297-9716-45-29","article-title":"Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins","volume":"45","author":"Kurtz","year":"2014","journal-title":"Vet. Res."},{"key":"10.1016\/j.vetmic.2024.110151_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-020-02527-9","article-title":"PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice","volume":"16","author":"Liu","year":"2020","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.vetmic.2024.110151_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/v7052321","article-title":"Alphaviruses in gene therapy","author":"Lundstrom","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.vetmic.2024.110151_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145130","article-title":"Self-amplifying rna viruses as rna vaccines","author":"Lundstrom","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.vetmic.2024.110151_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/1746-6148-2-6","article-title":"Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease","volume":"2","author":"Meerts","year":"2006","journal-title":"BMC Vet. Res"},{"key":"10.1016\/j.vetmic.2024.110151_bib28","doi-asserted-by":"crossref","DOI":"10.4236\/ojas.2015.54045","article-title":"Molecular Significance of lon and cpxR Genes in the Pathogenicity of Salmonella","volume":"05","author":"Nandre","year":"2015","journal-title":"Open J. Anim. Sci."},{"key":"10.1016\/j.vetmic.2024.110151_bib29","doi-asserted-by":"crossref","DOI":"10.1099\/0022-1317-81-9-2281","article-title":"Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein","volume":"81","author":"Nawagitgul","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vetmic.2024.110151_bib30","article-title":"Pathological evaluation of porcine circovirus 2d (PCV2d) strain and comparative evaluation of PCV2d and PCV2b Inactivated Vaccines against PCV2d Infection in a Specific Pathogen-Free (SPF) Yucatan Miniature Pig Model","volume":"10","author":"Noh","year":"2022","journal-title":"Vaccin. (Basel)"},{"key":"10.1016\/j.vetmic.2024.110151_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/tbed.13975","article-title":"The prevalence of porcine circovirus type 2e (PCV2e) in Korean slaughter pig lymph nodes when compared with other PCV2 genotypes","volume":"68","author":"Park","year":"2021","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.vetmic.2024.110151_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051339","article-title":"An mRNA-based multiple antigenic gene expression system delivered by engineered salmonella for severe fever with thrombocytopenia syndrome and assessment of its immunogenicity and protection using a human DC-SIGN-transduced mouse model","volume":"15","author":"Park","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vetmic.2024.110151_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2008.07.034","article-title":"Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs","volume":"154","author":"P\u00e9rez-Mart\u00edn","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.vetmic.2024.110151_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s11262-016-1326-x","article-title":"Interactions of porcine circovirus 2 with its hosts","author":"Ren","year":"2016","journal-title":"Virus Genes"},{"key":"10.1016\/j.vetmic.2024.110151_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121226","article-title":"Eukaryotic expression system complemented with expressivity of Semliki Forest Virus\u2019s RdRp and invasiveness of engineered Salmonella demonstrate promising potential for bacteria mediated gene therapy","volume":"279","author":"Senevirathne","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.vetmic.2024.110151_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2008.10.028","article-title":"Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus Type 2","volume":"46","author":"Shang","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.vetmic.2024.110151_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153289","article-title":"Matrine exhibits antiviral activity in a PRRSV\/PCV2 co-infected mouse model","volume":"77","author":"Sun","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.vetmic.2024.110151_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/1348-0421.12158","article-title":"Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice","volume":"58","author":"Sylla","year":"2014","journal-title":"Microbiol Immunol."},{"key":"10.1016\/j.vetmic.2024.110151_bib39","doi-asserted-by":"crossref","DOI":"10.1089\/apb.2022.0037","article-title":"Viral replicon systems and their biosafety aspects","author":"Van Der Meulen","year":"2023","journal-title":"Appl. Biosaf."},{"key":"10.1016\/j.vetmic.2024.110151_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2017.04.008","article-title":"Current state and challenges in developing oral vaccines","author":"Vela Ramirez","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vetmic.2024.110151_bib41","doi-asserted-by":"crossref","DOI":"10.1078\/1438-4221-00248","article-title":"Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp","author":"Weiss","year":"2003","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.vetmic.2024.110151_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2012.01.008","article-title":"Oral vaccination with attenuated Salmonella enterica serovar Typhimurium expressing Cap protein of PCV2 and its immunogenicity in mouse and swine models","volume":"157","author":"Xu","year":"2012","journal-title":"Vet. Microbiol"},{"key":"10.1016\/j.vetmic.2024.110151_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02409-20","article-title":"Correction for Zhan et al., \u201cThe Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation","volume":"95","author":"Zhan","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.vetmic.2024.110151_bib44","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.2019.20.e35","article-title":"Enhanced protective immune response to PCV2 adenovirus vaccine by fusion expression of Cap protein with InvC in pigs","volume":"20","author":"Zhang","year":"2019","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.vetmic.2024.110151_bib45","article-title":"Recombinant flagellin-porcine circovirus type 2 cap fusion protein promotes protective immune responses in mice","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"}],"container-title":["Veterinary Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378113524001731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378113524001731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T19:36:38Z","timestamp":1728070598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378113524001731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":45,"alternative-id":["S0378113524001731"],"URL":"https:\/\/doi.org\/10.1016\/j.vetmic.2024.110151","relation":{},"ISSN":["0378-1135"],"issn-type":[{"value":"0378-1135","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative immunogenic and immunoprotective activities of PCV2d Cap and Rep antigens delivered by an efficient eukaryotic expression system engineered into a Salmonella vaccine vector","name":"articletitle","label":"Article Title"},{"value":"Veterinary Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetmic.2024.110151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110151"}}